| Pre-phase (N = 67, 49.6%) | Post-phase (N = 68, 50.4%) | Overall (N = 135) | p-value |
---|---|---|---|---|
Etiology | Â | Â | Â | 0.06 |
 Enterobacteriaceae | 63 (95.5) | 59 (86.8) | 122 (91) | 0.15 |
  Klebsiella spp. | 39 (61.9) | 27 (45.8) | 66 (54.1) |  |
  E. coli | 12 (19.0) | 16 (27.1) | 28 (23.0) |  |
  Enterobacter spp. | 8 (12.7) | 6 (10.2) | 14 (11.5) |  |
  Proteus spp. | 3 (4.8) | 2 (3.4) | 5 (4.1) |  |
  Serratia spp. | 0 (0) | 3 (5.1) | 3 (2.5) |  |
 Pseudomonas spp. | 1 (1.5) | 7 (10.3) | 8 (6.0) |  |
 Acinetobacter spp. | 1 (1.5) | 2 (2.9) | 3 (2.2) |  |
Pattern of resistance | Â | Â | Â | Â |
 Wild-type | 26 (40.0) | 32 (47.1) | 58 (43.6) | 0.49 |
 ESBL-E | 18 (27.7) | 18 (26.5) | 36 (27.1) | 1 |
 Carbapenem-resistant | 18 (27.7) | 11 (16.2) | 29 (21.8) | 0.14 |
  KPC | 17 (25.4) | 8 (11.8) | 25 (18.5) | 0.002 |
 DTR | 19 (28.4) | 15 (22.1) | 34 (25.2) | 0.32 |